3 results
To evaluate the tumor targeting performance of the human radiolabeled antibody 124I-F16SIP.To investigate pharmacokinetics/-dynamics of 124I-F16SIP, and to assess its uptake in tumor and normal tissues as obtained from the surgical specimen.
Post-market clinical follow-up of a magnetic bone conduction implant (Cochlear Baha® Attract System)
This post-market clinical follow-up investigation aims to evaluate the usability and the mid- to long-term performance of the Baha Attract System in terms of hearing outcomes and safety. The objective is to compare the hearing performance with the…
Primary:• To compare the efficacy of magrolimab + venetoclax + azacitidine versus placebo + venetoclax + azacitidine in patients with previously untreated acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy as measured by…